Yep poor choice of words on my part. Leaving it to the last day, when holders have to decide on that same day whether to participate in a cr, was what I was getting at.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress